NFKB1 and ovarian carcinoma: In view of the fact that morin is a known inhibitor of NF-κB, which in turn may influence the expression of galectin-3 (the anti-apoptotic protein), we hypothesized that morin will sensitize ovarian cancer cells to cisplatin, what will be achieved by reducing the expression of galectin-3.